The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24.
The new add-on CPT code describes the adjunctive placement of a bone-anchored annular closure device, such as the devicemaker’s Barricaid, after lumbar discectomy in patients with large annular defects, according to a news release. The code’s descriptor reads “with repair of annular defect by implantation of bone-anchored annular closure device, including all imaging guidance, 1 interspace, lumbar (list separately in addition to code for primary procedure).”
In 2024 Barricaid earned a Category 1 CPT code from the AMA.
“Surgeons will now be able to code for the specific work of repairing an annular defect and implanting Barricaid following a discectomy,” April Spillane, vice president of health economics at Intrinsic Therapeutics, said in the release. “It is my sincere hope that this development will increase patient access to Barricaid.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
